2501 - 2550 of 7939 Results
Title
Year
-
OPENTitle: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 267End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212851Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/248871/248871.pdfCitation Count: 34
-
RESTRICTEDTitle: Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1181End Page: 1188Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13347Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13347Citation Count: 19
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 142
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Citation Count: 104
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 8
-
OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257372&type=printableCitation Count: 29
-
OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
RESTRICTEDTitle: Then and Now: 20 Years of Monumental Strides in Movement DisordersJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1Citation Count: 0
-
RESTRICTEDTitle: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 196End Page: 200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28805Citation Count: 24
-
RESTRICTEDTitle: Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase ActivityJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2719End Page: 2730Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28815Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28815Citation Count: 22
-
OPENTitle: Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard ScoreJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 62End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28808Best OA location URL: https://www.duo.uio.no/bitstream/10852/89465/2/Genetic%2bStratification%2bof%2bAge-Dependent%2bParkinson%2527s%2bDisease%2bRisk%2bby%2bPolygenic%2bHazard%2bScore.pdfCitation Count: 15
-
RESTRICTEDTitle: Increased functional connectivity in a population at risk of developing Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026Citation Count: 4
-
OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 32
-
OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 2
-
OPENTitle: Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 6Start Page: 888End Page: 900Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab294Best OA location URL: https://academic.oup.com/hmg/article-pdf/31/6/888/42993647/ddab294.pdfCitation Count: 27
-
OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28814Citation Count: 20
-
OPENTitle: Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 10Start Page: e2128204End Page: e2128204Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.28204Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784765/jankovic_2021_oi_210819_1632849263.95.pdfCitation Count: 27
-
RESTRICTEDTitle: Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2469End Page: 2478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10812-2Citation Count: 17
-
RESTRICTEDTitle: European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulationJournal Name: European Child & Adolescent PsychiatryPublisher: Springer Science and Business Media LLCVol: 31Issue #: 3Start Page: 443End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00787-021-01881-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00787-021-01881-9.pdfCitation Count: 33
-
RESTRICTEDTitle: Early‐Onset Parkinson's Disease: A Novel Deletion Comprising the DJ‐1 and TNFRSF9 GenesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2973End Page: 2976Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28812Citation Count: 9
-
OPENTitle: T-cell based immunotherapies for Parkinson’s diseaseJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol: 1Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2021.00007Best OA location URL: https://www.explorationpub.com/uploads/Article/A10047/10047.pdfCitation Count: 7
-
RESTRICTEDTitle: Parkinson’s Disease Videos on YouTube: Types and Characteristics of Content on Communication and CognitionJournal Name: Journal of Consumer Health on the InternetPublisher: Informa UK LimitedVol: 25Issue #: 4Start Page: 335End Page: 349Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15398285.2021.1980692Citation Count: 2
-
OPENTitle: Predicting Parkinson’s Disease and Its Pathology via Simple Clinical VariablesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 341End Page: 351Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212876Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212876?id=journal-of-parkinsons-disease%2Fjpd212876Citation Count: 11
-
OPENTitle: 146th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: S27Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26180Best OA location URL: http://bura.brunel.ac.uk/bitstream/2438/24148/3/MeetingAbstract.pdfCitation Count: 14
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 49
-
OPENTitle: Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab281Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab281/41780538/fcab281.pdfCitation Count: 18
-
OPENTitle: Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.08.008Best OA location URL: https://www.medrxiv.org/content/medrxiv/early/2021/07/22/2021.07.20.21260819.full.pdfCitation Count: 8
-
RESTRICTEDTitle: Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP‐RS and vPSPJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2449End Page: 2451Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28757Citation Count: 1
- Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability2021OPENTitle: Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerabilityJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab269Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab269/41729026/fcab269.pdfCitation Count: 38
-
RESTRICTEDTitle: Clinical and Dopamine Transporter Imaging Trajectories in a Cohort of Parkinson's Disease Patients with GBA MutationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 106End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28818Citation Count: 18
-
OPENTitle: ECTRIMS 2021 – ePosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 27Issue #: 2_supplStart Page: 134End Page: 740Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585211044667Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585211044667Citation Count: 25
-
OPENTitle: ECTRIMS 2021 – Late Breaking News ePosterJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 27Issue #: 2_supplStart Page: 752End Page: 804Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/13524585211047080Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/13524585211047080Citation Count: 1
-
RESTRICTEDTitle: Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 10Start Page: 1262End Page: 1262Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.1312Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017381Citation Count: 75
- Enhanced arm swing improves Parkinsonian gait with EEG power modulations resembling healthy gait2021OPENTitle: Enhanced arm swing improves Parkinsonian gait with EEG power modulations resembling healthy gaitJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 96End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003400/pdfCitation Count: 12
-
RESTRICTED
-
OPENTitle: Heat Shock Protein 70 as a Sex-Skewed Regulator of α-SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2541End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01114-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01114-6.pdfCitation Count: 6
-
RESTRICTEDTitle: In-Home Falls Risk Assessment in Parkinson Disease: A Guide for CliniciansJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 102Issue #: 10Start Page: 2051End Page: 2054Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2021.04.001Citation Count: 2
- Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transport2021RESTRICTEDTitle: Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transportJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of LipidsPublisher: Elsevier BVVol: 1866Issue #: 10Start Page: 159003End Page: 159003Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.bbalip.2021.159003Best OA location URL: https://doi.org/10.1016/j.bbalip.2021.159003Citation Count: 70
-
RESTRICTEDTitle: Longitudinal risk factors for developing depressive symptoms in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 429Issue #:Start Page: 117615End Page: 117615Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jns.2021.117615Best OA location URL: http://manuscript.elsevier.com/S0022510X21003099/pdf/S0022510X21003099.pdfCitation Count: 5
-
RESTRICTEDTitle: Mendelian Randomization Studies: A Path to Better Understand Sex and Gender Differences in Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2220End Page: 2222Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28765Citation Count: 4
-
OPENTitle: MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse BrainJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2529End Page: 2540Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01130-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01130-6.pdfCitation Count: 13
-
OPENTitle: ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 91Issue #:Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.024Best OA location URL: http://www.prd-journal.com/article/S1353802021003539/pdfCitation Count: 32
-
OPENTitle: Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab251Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab251/41152899/fcab251.pdfCitation Count: 6
-
RESTRICTEDTitle: Parkinson Disease: Translating Insights from Molecular Mechanisms to NeuroprotectionJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 73Issue #: 4Start Page: 1204End Page: 1268Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pharmrev.120.000189Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/73/4/1204.full.pdfCitation Count: 10
-
RESTRICTEDTitle: Restoring lost nigrostriatal fibers in Parkinson’s disease based on clinically-inspired design criteriaJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 175Issue #:Start Page: 168End Page: 185Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.07.016Best OA location URL: https://doi.org/10.1016/j.brainresbull.2021.07.016Citation Count: 15
-
RESTRICTEDTitle: Small Molecule Metabolites at the Host–Microbiota InterfaceJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 207Issue #: 7Start Page: 1725End Page: 1733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.2100528Best OA location URL: https://www.jimmunol.org/content/jimmunol/207/7/1725.full.pdfCitation Count: 16
-
RESTRICTEDTitle: Tardive Dyskinesia in Older Persons Taking AntipsychoticsJournal Name: Neuropsychiatric Disease and TreatmentPublisher: Informa UK LimitedVol: Volume 17Issue #:Start Page: 3127End Page: 3134Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/ndt.s328301Best OA location URL: https://www.dovepress.com/getfile.php?fileID=74946Citation Count: 10
-
OPENTitle: Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matchedJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 56Issue #:Start Page: 102558End Page: 102558Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102558Best OA location URL: https://doi.org/10.1016/j.scr.2021.102558Citation Count: 3